Search

Your search keyword '"Karanja DM"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Karanja DM" Remove constraint Author: "Karanja DM"
50 results on '"Karanja DM"'

Search Results

1. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

2. Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.

3. Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya.

4. Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.

5. Predictive Value of School-Aged Children's Schistosomiasis Prevalence and Egg Intensity for Other Age Groups in Western Kenya.

6. Is PCR the Next Reference Standard for the Diagnosis of Schistosoma in Stool? A Comparison with Microscopy in Senegal and Kenya.

7. Evaluation of point-of-contact circulating cathodic antigen assays for the detection of Schistosoma mansoni infection in low-, moderate-, and high-prevalence schools in western Kenya.

8. Cost analysis of tests for the detection of Schistosoma mansoni infection in children in western Kenya.

9. Improved sensitivity of the urine CAA lateral-flow assay for diagnosing active Schistosoma infections by using larger sample volumes.

10. Using Photovoice as a Community Based Participatory Research Tool for Changing Water, Sanitation, and Hygiene Behaviours in Usoma, Kenya.

11. Dreaming of toilets: using photovoice to explore knowledge, attitudes and practices around water-health linkages in rural Kenya.

12. Social capital, collective action and access to water in rural Kenya.

13. Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment.

14. Use of geospatial modeling to predict Schistosoma mansoni prevalence in Nyanza Province, Kenya.

15. Association between CD4+ T-lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy.

16. High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya.

17. Community health workers' experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project.

18. Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya.

19. Mechanism of anemia in Schistosoma mansoni-infected school children in Western Kenya.

20. Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya - a pilot study.

21. Faecal contamination of public water sources in informal settlements of Kisumu City, western Kenya.

22. Malacological survey and geographical distribution of vector snails for schistosomiasis within informal settlements of Kisumu City, western Kenya.

23. Geographical distribution of schistosomiasis and soil-transmitted helminths among school children in informal settlements in Kisumu City, Western Kenya.

24. You cannot prevent a disease; you only treat diseases when they occur: knowledge, attitudes and practices to water-health in a rural Kenyan community.

25. Identification of cytokeratin 18 as a biomarker of mouse and human hepatosplenic schistosomiasis.

26. Schistosomiasis among young children in Usoma, Kenya.

27. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya.

28. Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

29. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

30. Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.

31. Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

32. Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.

33. Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni.

34. The life history and in vivo culture of Coelomomyces utahensis (Blastocladiomycetes).

35. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.

36. Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni.

37. Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.

38. Origin and diversification of the human parasite Schistosoma mansoni.

39. Short report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1.

40. Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya.

41. Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection.

42. Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment.

43. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study.

44. Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection.

45. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals.

46. Knowledge and attitudes to malaria control and acceptability of permethrin impregnated sisal curtains.

47. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.

48. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections.

49. Some observations on the biting behavior of Anopheles gambiae s.s., Anopheles arabiensis, and Anopheles funestus and their implications for malaria control.

50. Small-scale field evaluation of the monomolecular surface film 'Arosurf MSF' against Anopheles arabiensis Patton.

Catalog

Books, media, physical & digital resources